Global Report Center
Finance

Most FDA advisers say peptides like BPC-157 and TB-500 should be made available in the U.S. Here’s what happens next.

The FDA is deciding whether seven peptides can be legally compounded, potentially opening the door to broader use in Americans.

Global Report Center
- 1 min read
Most FDA advisers say peptides like BPC-157 and TB-500 should be made available in the U.S. Here’s what happens next.

The FDA is deciding whether seven peptides can be legally compounded, potentially opening the door to broader use in Americans.

Article length: 20 words.